Variant report
Variant | nsv518676 |
---|---|
Chromosome Location | chr3:80403233-80410159 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:80398298..80401039-chr3:80402529..80404343,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs576386194 | chr3:80404210-80404211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs140044108 | chr3:80404218-80404219 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs6548689 | chr3:80404220-80404221 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs143567290 | chr3:80404246-80404247 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs546527869 | chr3:80404268-80404269 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs146824254 | chr3:80404307-80404308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs545802817 | chr3:80404316-80404317 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs6800923 | chr3:80404318-80404319 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs71326418 | chr3:80404337-80404338 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs561161973 | chr3:80404367-80404368 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs376727498 | chr3:80404384-80404385 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs541931831 | chr3:80404386-80404387 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs4856613 | chr3:80404392-80404393 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs550455804 | chr3:80404397-80404398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs570302338 | chr3:80404408-80404409 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs546530799 | chr3:80404425-80404426 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs538621131 | chr3:80404430-80404431 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs567862576 | chr3:80404474-80404475 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs73117719 | chr3:80404477-80404478 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs17017893 | chr3:80404501-80404502 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs534727199 | chr3:80404512-80404513 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs369886100 | chr3:80404523-80404524 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs371523812 | chr3:80404548-80404549 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs574693583 | chr3:80404549-80404550 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs536899636 | chr3:80404573-80404574 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs57035864 | chr3:80404598-80404599 | Flanking Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs577098252 | chr3:80404609-80404610 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs143774355 | chr3:80404611-80404612 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs560334973 | chr3:80404639-80404640 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs58502760 | chr3:80404689-80404690 | Flanking Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs184047752 | chr3:80404694-80404695 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs372531933 | chr3:80404714-80404715 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs561102379 | chr3:80404790-80404791 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs369220306 | chr3:80404822-80404823 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs151079477 | chr3:80404857-80404858 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs563989876 | chr3:80404861-80404862 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs189017713 | chr3:80404892-80404893 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs116668170 | chr3:80404897-80404898 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs565691968 | chr3:80404904-80404905 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs192997235 | chr3:80404917-80404918 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs28693406 | chr3:80404933-80404934 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs12637470 | chr3:80404954-80404955 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs185098564 | chr3:80404971-80404972 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs568037938 | chr3:80404976-80404977 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs537241225 | chr3:80405012-80405013 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs529169304 | chr3:80405023-80405024 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs556906438 | chr3:80405035-80405036 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs12634980 | chr3:80405043-80405044 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs187050142 | chr3:80405066-80405067 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs572113833 | chr3:80405083-80405084 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute myeloid leukemia | 20729466 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Melanoma | 18172304 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Wilms tumour | 21544195 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 21399695 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Mental retardation | 17124404 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Autism | 20808228 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:80404200-80404400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
2 | chr3:80404200-80405200 | Enhancers | NHEK | skin |
3 | chr3:80404400-80404800 | Flanking Active TSS | Foreskin Keratinocyte Primary Cells skin03 | Skin |
4 | chr3:80404800-80405800 | Active TSS | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr3:80405200-80406600 | Weak transcription | NHEK | skin |
6 | chr3:80405800-80406000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
7 | chr3:80406000-80406800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
8 | chr3:80406600-80407400 | Enhancers | NHEK | skin |
9 | chr3:80406800-80407400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |